Article
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
Hepatobiliary & pancreatic diseases international : HBPD INT - 1 May 2002
Yang Dan-Hong, Liang Wei-Feng, Xie Yuan-Jun, Zhao Nian-Feng, Fan Jun
Abstract excerpt
OBJECTIVE: To analyse the emergence of YMDD motif (tyrosine-methionine-aspartate-aspartate) variants in patients with hepatitis B treated with lamivudine. METHODS: The amino acid substitution from methionine or isoleucine at the YMDD motif at the HBV polymerase gene is a main mutation resistant to lamivudine treatment. Generated from a fragment of domain C of the polymerase gene, patients' HBV DNA, which had been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
